This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharma Deutschland, Gmbh. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Martin Albert Knauf: Innovator in Stromelysin Inhibitors
Introduction
Martin Albert Knauf is a notable inventor based in Frankfurt, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stromelysin inhibitors. His work has implications for various medical applications, showcasing his innovative spirit and dedication to advancing healthcare.
Latest Patents
Martin Albert Knauf holds 1 patent related to stromelysin inhibitors. This patent reflects his commitment to addressing critical health challenges through innovative solutions.
Career Highlights
Knauf is currently employed at Aventis Pharma Deutschland GmbH, where he continues to contribute to pharmaceutical research and development. His role at the company allows him to collaborate with other experts in the field and push the boundaries of medical science.
Collaborations
Some of his notable coworkers include Cordula Hopmann and Klaus-Ulrich Weithmann. Their collective expertise enhances the innovative environment at Aventis Pharma, fostering advancements in pharmaceutical research.
Conclusion
Martin Albert Knauf exemplifies the spirit of innovation in the pharmaceutical industry. His work on stromelysin inhibitors and collaboration with esteemed colleagues highlight his valuable contributions to medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile